Qun Shi

Key Laboratory Of Rheumatology & Clinical Immunology
Beijing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Iguratimod treatment reduces disease activity in early primary Sjögren's syndrome: An open-label pilot study.

Iguratimod treatment reduces disease activity in early primary Sjögren's syndrome: An open-label pilot study.

Journal: Modern rheumatology

Published: July 03, 2020

UPLC-MS based plasma metabolomics and lipidomics reveal alterations associated with IgG4-related disease.

UPLC-MS based plasma metabolomics and lipidomics reveal alterations associated with IgG4-related disease.

Journal: Rheumatology (Oxford, England)

Published: June 05, 2020

Metagenomic profiling of the pro-inflammatory gut microbiota in ankylosing spondylitis.

Metagenomic profiling of the pro-inflammatory gut microbiota in ankylosing spondylitis.

Journal: Journal of autoimmunity

Published: October 04, 2019

Complement C1q synergizes with PTX3 in promoting NLRP3 inflammasome over-activation and pyroptosis in rheumatoid arthritis.

Complement C1q synergizes with PTX3 in promoting NLRP3 inflammasome over-activation and pyroptosis in rheumatoid arthritis.

Journal: Journal of autoimmunity

Published: August 19, 2019

Different clinical patterns of IgG4-RD patients with and without eosinophilia.

Different clinical patterns of IgG4-RD patients with and without eosinophilia.

Journal: Scientific reports

Published: May 20, 2019

Efficacy and safety of iguratimod plus corticosteroid as bridge therapy in treating mild IgG4-related diseases: A prospective clinical trial.

Efficacy and safety of iguratimod plus corticosteroid as bridge therapy in treating mild IgG4-related diseases: A prospective clinical trial.

Journal: International journal of rheumatic diseases

Published: January 28, 2019

Comparison of the impact of Tripterygium wilfordii Hook F and Methotrexate treatment on radiological progression in active rheumatoid arthritis: 2-year follow up of a randomized, non-blinded, controlled study.

Comparison of the impact of Tripterygium wilfordii Hook F and Methotrexate treatment on radiological progression in active rheumatoid arthritis: 2-year follow up of a randomized, non-blinded, controlled study.

Journal: Arthritis research & therapy

Published: December 03, 2017

Serum IgG subclasses in autoimmune diseases.

Serum IgG subclasses in autoimmune diseases.

Journal: Medicine

Published: January 16, 2015

Response to D.M. Marcus's comment on the TRIFRA study (comparison of Tripterygium wilfordii Hook F vs methotrexate in the treatment of active rheumatoid arthritis).

Response to D.M. Marcus's comment on the TRIFRA study (comparison of Tripterygium wilfordii Hook F vs methotrexate in the treatment of active rheumatoid arthritis).

Journal: Annals of the rheumatic diseases

Published: August 03, 2014

TwHF versus methotrexate in the treatment of rheumatoid arthritis: response to Landewe's comment on the TRIFRA study.

TwHF versus methotrexate in the treatment of rheumatoid arthritis: response to Landewe's comment on the TRIFRA study.

Journal: Annals of the rheumatic diseases

Published: July 27, 2014

The TRIFRA trial: efforts employed to minimise expectation bias.

The TRIFRA trial: efforts employed to minimise expectation bias.

Journal: Annals of the rheumatic diseases

Published: July 25, 2014

Clinical characteristics of immunoglobulin G4-related disease: a prospective study of 118 Chinese patients.

Clinical characteristics of immunoglobulin G4-related disease: a prospective study of 118 Chinese patients.

Journal: Rheumatology (Oxford, England)

Published: May 21, 2014

Showing 1-12 of 21

Last Updated: 09/26/2026